vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $617.8M, roughly 1.6× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -1.1%, a 4.4% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 28.4%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-55.4M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 26.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

ALHC vs HIMS — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.6× larger
ALHC
$1.0B
$617.8M
HIMS
Growing faster (revenue YoY)
ALHC
ALHC
+16.0% gap
ALHC
44.4%
28.4%
HIMS
Higher net margin
HIMS
HIMS
4.4% more per $
HIMS
3.3%
-1.1%
ALHC
More free cash flow
HIMS
HIMS
$52.9M more FCF
HIMS
$-2.5M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
26.9%
ALHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
HIMS
HIMS
Revenue
$1.0B
$617.8M
Net Profit
$-11.0M
$20.6M
Gross Margin
71.9%
Operating Margin
-1.0%
1.5%
Net Margin
-1.1%
3.3%
Revenue YoY
44.4%
28.4%
Net Profit YoY
64.6%
-20.8%
EPS (diluted)
$-0.04
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
HIMS
HIMS
Q4 25
$1.0B
$617.8M
Q3 25
$993.7M
$599.0M
Q2 25
$1.0B
$544.8M
Q1 25
$926.9M
$586.0M
Q4 24
$701.2M
$481.1M
Q3 24
$692.4M
$401.6M
Q2 24
$681.3M
$315.6M
Q1 24
$628.6M
$278.2M
Net Profit
ALHC
ALHC
HIMS
HIMS
Q4 25
$-11.0M
$20.6M
Q3 25
$3.7M
$15.8M
Q2 25
$15.7M
$42.5M
Q1 25
$-9.1M
$49.5M
Q4 24
$-31.1M
$26.0M
Q3 24
$-26.4M
$75.6M
Q2 24
$-24.0M
$13.3M
Q1 24
$-46.5M
$11.1M
Gross Margin
ALHC
ALHC
HIMS
HIMS
Q4 25
71.9%
Q3 25
73.8%
Q2 25
76.4%
Q1 25
73.5%
Q4 24
76.8%
Q3 24
79.2%
Q2 24
81.3%
Q1 24
82.4%
Operating Margin
ALHC
ALHC
HIMS
HIMS
Q4 25
-1.0%
1.5%
Q3 25
0.8%
2.0%
Q2 25
2.2%
4.9%
Q1 25
-0.6%
9.9%
Q4 24
-3.2%
3.9%
Q3 24
-2.8%
5.6%
Q2 24
-2.7%
3.5%
Q1 24
-6.5%
3.6%
Net Margin
ALHC
ALHC
HIMS
HIMS
Q4 25
-1.1%
3.3%
Q3 25
0.4%
2.6%
Q2 25
1.5%
7.8%
Q1 25
-1.0%
8.4%
Q4 24
-4.4%
5.4%
Q3 24
-3.8%
18.8%
Q2 24
-3.5%
4.2%
Q1 24
-7.4%
4.0%
EPS (diluted)
ALHC
ALHC
HIMS
HIMS
Q4 25
$-0.04
$0.08
Q3 25
$0.02
$0.06
Q2 25
$0.07
$0.17
Q1 25
$-0.05
$0.20
Q4 24
$-0.15
$0.10
Q3 24
$-0.14
$0.32
Q2 24
$-0.13
$0.06
Q1 24
$-0.25
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
HIMS
HIMS
Cash + ST InvestmentsLiquidity on hand
$604.2M
$228.6M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$540.9M
Total Assets
$1.1B
$2.2B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
HIMS
HIMS
Q4 25
$604.2M
$228.6M
Q3 25
$644.1M
$345.8M
Q2 25
$503.8M
$1.1B
Q1 25
$479.5M
$273.7M
Q4 24
$470.6M
$220.6M
Q3 24
$381.0M
$165.5M
Q2 24
$363.7M
$129.3M
Q1 24
$301.7M
$105.2M
Total Debt
ALHC
ALHC
HIMS
HIMS
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
HIMS
HIMS
Q4 25
$179.3M
$540.9M
Q3 25
$161.9M
$581.0M
Q2 25
$141.0M
$562.7M
Q1 25
$108.1M
$549.3M
Q4 24
$99.9M
$476.7M
Q3 24
$114.5M
$440.1M
Q2 24
$123.7M
$362.0M
Q1 24
$130.9M
$344.5M
Total Assets
ALHC
ALHC
HIMS
HIMS
Q4 25
$1.1B
$2.2B
Q3 25
$1.1B
$2.2B
Q2 25
$1.0B
$1.9B
Q1 25
$895.6M
$891.7M
Q4 24
$782.1M
$707.5M
Q3 24
$692.3M
$602.3M
Q2 24
$716.3M
$480.5M
Q1 24
$633.2M
$448.1M
Debt / Equity
ALHC
ALHC
HIMS
HIMS
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
HIMS
HIMS
Operating Cash FlowLast quarter
$-50.4M
$61.3M
Free Cash FlowOCF − Capex
$-55.4M
$-2.5M
FCF MarginFCF / Revenue
-5.5%
-0.4%
Capex IntensityCapex / Revenue
0.5%
10.3%
Cash ConversionOCF / Net Profit
2.98×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$57.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
HIMS
HIMS
Q4 25
$-50.4M
$61.3M
Q3 25
$144.6M
$148.7M
Q2 25
$29.1M
$-19.1M
Q1 25
$16.6M
$109.1M
Q4 24
$-8.7M
$86.4M
Q3 24
$26.2M
$85.3M
Q2 24
$23.5M
$53.6M
Q1 24
$-6.2M
$25.8M
Free Cash Flow
ALHC
ALHC
HIMS
HIMS
Q4 25
$-55.4M
$-2.5M
Q3 25
$139.1M
$79.3M
Q2 25
$21.1M
$-69.5M
Q1 25
$8.4M
$50.1M
Q4 24
$-18.0M
$59.5M
Q3 24
$16.9M
$79.4M
Q2 24
$11.8M
$47.6M
Q1 24
$-17.4M
$11.8M
FCF Margin
ALHC
ALHC
HIMS
HIMS
Q4 25
-5.5%
-0.4%
Q3 25
14.0%
13.2%
Q2 25
2.1%
-12.8%
Q1 25
0.9%
8.5%
Q4 24
-2.6%
12.4%
Q3 24
2.4%
19.8%
Q2 24
1.7%
15.1%
Q1 24
-2.8%
4.3%
Capex Intensity
ALHC
ALHC
HIMS
HIMS
Q4 25
0.5%
10.3%
Q3 25
0.6%
11.6%
Q2 25
0.8%
9.3%
Q1 25
0.9%
10.1%
Q4 24
1.3%
5.6%
Q3 24
1.3%
1.5%
Q2 24
1.7%
1.9%
Q1 24
1.8%
5.0%
Cash Conversion
ALHC
ALHC
HIMS
HIMS
Q4 25
2.98×
Q3 25
38.77×
9.43×
Q2 25
1.86×
-0.45×
Q1 25
2.20×
Q4 24
3.32×
Q3 24
1.13×
Q2 24
4.03×
Q1 24
2.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons